Asit Parikh
CIK: 0001796787
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Phathom Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- May 22, 2026PHAT
Phathom Pharmaceuticals, Inc.
Gift(G)Direct28K shares- - May 22, 2026PHAT
Phathom Pharmaceuticals, Inc.
Gift(G)Indirect28K shares- - May 20, 2026PHAT
Phathom Pharmaceuticals, Inc.
Disposition(D)DirectCommon Stock (Right to Buy)
17.5K shares- - May 20, 2026PHAT
Phathom Pharmaceuticals, Inc.
Exercise(M)Direct17.5K shares at avg. $4.95$87K - May 19, 2026PHAT
Phathom Pharmaceuticals, Inc.
Award(A)Direct24.1K shares- - Mar 10, 2026PHAT
Phathom Pharmaceuticals, Inc.
Gift(G)Direct40K shares- - Mar 10, 2026PHAT
Phathom Pharmaceuticals, Inc.
Gift(G)Indirect40K shares- - Jan 23, 2026PHAT
Phathom Pharmaceuticals, Inc.
Gift(G)Direct80.5K shares- - Jan 23, 2026PHAT
Phathom Pharmaceuticals, Inc.
Gift(G)Indirect80.5K shares- - Jan 13, 2026PHAT
Phathom Pharmaceuticals, Inc.
Exercise(M)Direct8.8K shares at avg. $10.30$90K - Dec 19, 2025PHAT
Phathom Pharmaceuticals, Inc.
Exercise(M)Direct8.8K shares at avg. $10.30$90K - Jun 3, 2025PHAT
Phathom Pharmaceuticals, Inc.
Award(A)Direct10.5K shares- - May 7, 2025PHAT
Phathom Pharmaceuticals, Inc.
Purchase(P)Direct5K shares at avg. $2.40$12K - May 6, 2025PHAT
Phathom Pharmaceuticals, Inc.
Purchase(P)Direct5K shares at avg. $2.60$13K - Mar 13, 2025PHAT
Phathom Pharmaceuticals, Inc.
Purchase(P)Direct10K shares at avg. $4.42$44K - Dec 13, 2024PHAT
Phathom Pharmaceuticals, Inc.
Purchase(P)Direct10K shares at avg. $8.12$81K - Sep 10, 2024PHAT
Phathom Pharmaceuticals, Inc.
Exercise(M)Direct7.5K shares at avg. $11.72$88K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Gift(G) | 28,000 | - | $0 | Direct |
| May 22, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Gift(G) | 28,000 | - | $0 | Indirect |
| May 20, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Disposition(D) Common Stock (Right to Buy) | 17,500 | - | - | Direct |
| May 20, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Exercise(M) | 17,500 | $4.95 | $86,625 | Direct |
| May 19, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Award(A) | 24,122 | - | $0 | Direct |
| Mar 10, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Gift(G) | 40,000 | - | $0 | Direct |
| Mar 10, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Gift(G) | 40,000 | - | $0 | Indirect |
| Jan 23, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Gift(G) | 80,500 | - | $0 | Direct |
| Jan 23, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Gift(G) | 80,500 | - | $0 | Indirect |
| Jan 13, 2026 | PHAT Phathom Pharmaceuticals, Inc. | Exercise(M) | 8,750 | $10.30 | $90,125 | Direct |
| Dec 19, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Exercise(M) | 8,750 | $10.30 | $90,125 | Direct |
| Jun 3, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award(A) | 10,500 | - | - | Direct |
| May 7, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Purchase(P) | 5,000 | $2.40 | $11,985 | Direct |
| May 6, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Purchase(P) | 5,000 | $2.60 | $13,000 | Direct |
| Mar 13, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Purchase(P) | 10,000 | $4.42 | $44,200 | Direct |
| Dec 13, 2024 | PHAT Phathom Pharmaceuticals, Inc. | Purchase(P) | 10,000 | $8.12 | $81,248 | Direct |
| Sep 10, 2024 | PHAT Phathom Pharmaceuticals, Inc. | Exercise(M) | 7,500 | $11.72 | $87,900 | Direct |
1-17 of 17 transactions
About Parikh Asit
Parikh Asit (SEC CIK 0001796787) files insider reports with the SEC as Director of Phathom Pharmaceuticals, Inc. (PHAT).
Signal8 holds 11 ownership filings by Parikh Asit, all Form 4s, filed between Dec 16, 2024 and May 27, 2026. Those filings report 17 transactions, from Sep 10, 2024 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Parikh Asit's filings is in FLORHAM PARK, NJ.
Recent filings by Parikh Asit
- May 22, 2026: Gifts of PHAT shares (2 lines, Form 4, code G).
- May 20, 2026: Disposition to issuer transaction of PHAT derivative securities (Form 4, code D).
- May 20, 2026: Option exercise of PHAT shares (Form 4, code M).
- May 19, 2026: Grant or award of PHAT shares (Form 4, code A).
- Mar 10, 2026: Gifts of PHAT shares (2 lines, Form 4, code G).
Other insiders filing for Phathom Pharmaceuticals, Inc. (PHAT)
- Narula Sanjeev, Chief Financial & Bus. Officer
- Breedlove Robert Charles, Principal Accounting Officer
- Topper James N, Director
- Stenhouse Mark, Director
- FIELDS HEIDI, Director
- COLA MICHAEL F, Director